Racial and ethnic disparities in access to total neoadjuvant therapy for rectal cancer

被引:0
|
作者
Chan, Michelle [1 ]
Rajasekar, Ganesh [2 ]
Arnow, Katherine D. [2 ]
Wagner, Todd H. [2 ,3 ]
Dawes, Aaron J. [1 ,2 ]
机构
[1] Stanford Univ, Sch Med, Dept Surg, Sect Colon & Rectal Surg, Stanford, CA 94305 USA
[2] Stanford Surg Policy Improvement Res & Educ Ctr, Dept Surg, Stanford, CA USA
[3] VA Palo Alto Hlth Care Syst, Hlth Econ Resource Ctr, Menlo Pk, CA USA
关键词
PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; OUTCOMES; CHEMOTHERAPY; SURGERY;
D O I
10.1016/j.surg.2024.06.022
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Total neoadjuvant therapy has revolutionized the treatment of locally advanced rectal cancer and quickly become the new standard of care. Whether patients from all racial and ethnic groups have had equal access to these potential benefits, however, remains unknown. Methods: We identified all adults diagnosed with locally advanced rectal cancer in California who underwent neoadjuvant chemotherapy and radiation from 2010 to 2020 using the California Cancer Registry. We used logistic regression to estimate the predicted probability of receiving total neoadjuvant therapy as opposed to traditional chemoradiotherapy for each racial and ethnic group and used a time-race interaction to evaluate trends in access to total neoadjuvant therapy over time. We also compared survival by racial and ethnic group and total neoadjuvant therapy status using Kaplan-Meier plots and Cox proportional hazards models. Results: In total, 6,856 patients met inclusion criteria. Overall, 36.6% of patients received total neoadjuvant therapy in 2010 compared with 66.3% in 2020. Latino patients were significantly less likely than non-Latino White patients to undergo total neoadjuvant therapy ; however, there was no difference in the rate of growth in total neoadjuvant therapy over time between racial and ethnic groups. Non-Latino Black patients appeared to have lower risk-adjusted survival compared with non-Latino White patients, although not among patients who underwent total neoadjuvant therapy . Conclusion: Access to total neoadjuvant therapy has increased significantly over time in California with no apparent difference in the rate of growth between racial and ethnic groups. We found no evidence of racial or ethnic disparities in survival among patients treated with total neoadjuvant therapy, suggesting that increasing access to high-quality cancer care may also improve health equity. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:1058 / 1064
页数:7
相关论文
共 50 条
  • [1] Racial Ethnic Disparities in Access to Neoadjuvant Therapy for Pancreatic Adenocarcinoma
    Kangas-Dick, A. W.
    Greenbaum, A. A.
    Gazivoda, V. P.
    Hilden, P. D.
    Gall, V. A.
    Sesti, J.
    Paul, S.
    August, D. A.
    Kennedy, T. J.
    Grandhi, M. S.
    Alexander, H. R.
    Maggi, J. C.
    Langan, R. C.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S91 - S91
  • [2] Overcoming Racial and Ethnic Disparities in Rectal Cancer Treatment
    Fritz, Cassandra D. L.
    Oduyale, Oluseye
    Cao, Yin
    JAMA NETWORK OPEN, 2024, 7 (02)
  • [3] Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma
    Lee, Wendy
    Nelson, Rebecca
    Akmal, Yasir
    Mailey, Brian
    McKenzie, Shaun
    Artinyan, Avo
    Ashing-Giwa, Kimlin Tam
    Chen, Yi-Jen
    Garcia-Aguilar, Julio
    Kim, Joseph
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2012, 27 (06) : 737 - 749
  • [4] Racial and ethnic disparities in outcomes with radiation therapy for rectal adenocarcinoma
    Wendy Lee
    Rebecca Nelson
    Yasir Akmal
    Brian Mailey
    Shaun McKenzie
    Avo Artinyan
    Kimlin Tam Ashing-Giwa
    Yi-Jen Chen
    Julio Garcia-Aguilar
    Joseph Kim
    International Journal of Colorectal Disease, 2012, 27 : 737 - 749
  • [5] Total neoadjuvant therapy in rectal cancer
    Gudrun Piringer
    Alexander De Vries
    memo - Magazine of European Medical Oncology, 2023, 16 : 21 - 30
  • [6] Total neoadjuvant therapy for rectal cancer
    Goodman, K. A.
    CANCER RADIOTHERAPIE, 2018, 22 (05): : 459 - 465
  • [7] Total neoadjuvant therapy in rectal cancer
    Piringer, Gudrun
    De Vries, Alexander
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (01) : 21 - 30
  • [8] Total neoadjuvant therapy for rectal cancer
    Hunt, Steven R.
    SEMINARS IN COLON AND RECTAL SURGERY, 2019, 30 (02) : 63 - 67
  • [9] Total Neoadjuvant Therapy for Rectal Cancer
    Affleck, Arthur G.
    Herzig, Daniel
    SURGICAL CLINICS OF NORTH AMERICA, 2024, 104 (03) : 609 - 617
  • [10] The conundrum of total neoadjuvant therapy in rectal cancer
    Ballal, Devesh S.
    Vispute, Tejas P.
    Saklani, Avanish P.
    COLORECTAL DISEASE, 2024, 26 (05) : 1068 - 1071